Inari Medical, Inc. is a commercial-stage medical device company dedicated to developing and commercializing innovative catheter-based technologies for the treatment of venous thromboembolism (VTE) and other venous diseases. Their flagship products, the ClotTriever® and FlowTriever® systems, are designed to remove large clots from large vessels, offering minimally invasive solutions for deep vein thrombosis (DVT) and pulmonary embolism (PE). Inari is focused on transforming the standard of care for patients suffering from these conditions by providing safe, effective, and less invasive treatment options.
The Irvine headquarters serves as the central hub for Inari Medical's strategic leadership, research and development, global operations, engineering, marketing, and administrative functions. It's where core product innovation and business strategy are driven.
The facility is a modern office and R&D space, likely equipped with advanced labs for medical device development and testing, designed to foster collaboration and innovation. It is situated in a prominent business park known for technology and life science companies.
Inari Medical fosters a patient-focused and mission-driven work culture. Employees often describe it as fast-paced and innovative, with a strong emphasis on teamwork, clinical excellence, and making a tangible impact on patients' lives. The culture encourages problem-solving and continuous improvement in the pursuit of better VTE treatments.
The Irvine headquarters is crucial as it anchors Inari Medical's operations in a key medtech ecosystem, facilitating access to talent, research partners, and a supportive business environment. It's the command center for their rapidly growing global commercial activities and product pipeline development.
Inari Medical has established a significant global presence, primarily focused on North America and Europe, with expanding activities in other international markets. Their innovative therapies for venous thromboembolism are utilized in numerous countries, supported by direct sales teams, clinical specialists, and distribution partners. The company actively pursues regulatory approvals and commercial expansion to make its ClotTriever and FlowTriever systems accessible to more patients worldwide, investing in physician training and clinical research globally.
6001 Oak Canyon, Suite 100
Irvine
CA
USA
Address: Dammstrasse 19, 6300 Zug, Switzerland
To expand Inari Medical's footprint in Europe, support clinical studies, provide training to physicians, and navigate the diverse healthcare systems across European countries, ensuring patients have access to their VTE treatment technologies.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Inari Medical' leadership includes:
Inari Medical has been backed by several prominent investors over the years, including:
Inari Medical has experienced notable executive leadership transitions over the past 12 months, including the appointment of a new CEO, Chief Commercial Officer, and Chief Legal and Compliance Officer, signaling strategic enhancements to its leadership team to support continued growth and market expansion.
Discover the tools Inari Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Inari Medical's email formats primarily follow the [first_initial][last]@inarimedical.com pattern (e.g., jsmith@inarimedical.com). This is the most common structure observed for employee email addresses.
[first_initial][last]@inarimedical.com
Format
dhykes@inarimedical.com
Example
85%
Success rate
investors.inarimedical.com • May 7, 2024
Inari Medical announced its financial results for the first quarter of 2024, reporting revenues of $143.2 million, an increase of 28.6% year-over-year. The company highlighted continued adoption of its ClotTriever and FlowTriever products and progress in its product pipeline....more
Business Wire (via investors.inarimedical.com) • February 29, 2024
Inari Medical presented late-breaking data from the CLOUT registry, demonstrating strong safety and effectiveness outcomes for the ClotTriever system in treating DVT across a large, diverse patient population in real-world clinical practice....more
Business Wire (via investors.inarimedical.com) • December 4, 2023
Inari Medical announced the appointment of Tara Dunn as Chief Legal and Compliance Officer and Corporate Secretary, effective December 4, 2023. Ms. Dunn brings over 20 years of legal and leadership experience in the medical device industry....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Inari Medical, are just a search away.